TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $321,000 | -3.0% | 4,260 | -38.5% | 0.00% | +100.0% |
| Q4 2021 | $331,000 | -29.0% | 6,929 | -1.2% | 0.00% | -50.0% |
| Q3 2021 | $466,000 | -46.7% | 7,012 | -37.4% | 0.00% | -50.0% |
| Q2 2021 | $874,000 | -15.1% | 11,202 | +2.9% | 0.00% | -20.0% |
| Q1 2021 | $1,030,000 | -51.8% | 10,885 | -37.9% | 0.01% | -44.4% |
| Q4 2020 | $2,136,000 | +40.9% | 17,527 | +1.0% | 0.01% | +28.6% |
| Q3 2020 | $1,516,000 | +303.2% | 17,352 | +198.4% | 0.01% | +250.0% |
| Q2 2020 | $376,000 | – | 5,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,737,297 | $176,802,000 | 6.75% |
| MPM BioImpact LLC | 308,686 | $19,938,000 | 5.30% |
| Burrage Capital Management LLC | 77,172 | $4,985,000 | 3.49% |
| Orbimed Advisors | 2,745,327 | $177,321,000 | 2.50% |
| Parkman Healthcare Partners LLC | 110,318 | $7,125,000 | 2.01% |
| SECTORAL ASSET MANAGEMENT INC | 284,486 | $18,375,000 | 1.69% |
| First Light Asset Management, LLC | 192,829 | $12,455,000 | 1.45% |
| Asymmetry Capital Management, L.P. | 22,608 | $1,460,000 | 1.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,236,000 | 0.74% |
| Prosight Management, LP | 25,602 | $1,654,000 | 0.71% |